|
Market Closed -
Nasdaq
16:00:00 2026-10-16 EDT
|
5-day change | 1st Jan Change | ||
| 0.7803 USD | -4.10% |
|
-18.34% | -42.20% |
| 09-14 | Ocugen Insider Sold Shares Worth $589,110, According to a Recent SEC Filing | MT |
| 09-01 | Ocugen Doses First Patient in Trial of Potential Eye Disease Drug | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| OCUGEN, INC. | Other Biotechnology & Medical Research | -4.10% | -18.34% | -42.20% | -51.23% | -90.99% | 265M |  | | |
- Stock Market
- Stocks
- OCGN Stock
- Charts Ocugen, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
